Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2019 | Advances in the treatment and prognosis of TTP

Paul Coppo • 13 Jun 2019
EHA 2019
Rare Diseases

Paul Coppo, MD, Saint-Antoine University Hospital, Paris, France, discusses advances in the treatment and prognosis of thrombotic thrombocytopenic purpura (TTP). This interview took place at the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands.

More from Paul Coppo

0:53
Promising TTP treatments on the horizon
Paul Coppo • 14 Jun 2019
1:24
Unmet needs in TTP
Paul Coppo • 13 Jun 2019

Related Videos

1:11
Personalized risk assessment for transplantation in primary immunodeficiency disorders
Thomas Fox • 15 Apr 2024
1:18
Autologous gene editing using the CRISPR system to treat primary immunodeficiency disorders
Thomas Fox • 15 Apr 2024
0:58
Hematological manifestations associated with primary immunodeficiency disorders
Thomas Fox • 15 Apr 2024
0:59
The common clinical manifestations of BPDCN
Anthony Stein • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals